Article information
La neuropatía autonómica diabética cardiovascular es un trastorno en el cual una alteración en la regulación del sistema nervioso cardiovascular, por parte del sistema nervioso autónomo, desemboca en una constelación de síntomas, que pueden ir desde intolerancia al ejercicio hasta muerte súbita. Si bien no se conoce su prevalencia exacta, se estima que es alta en pacientes diabéticos, particularmente en aquellos con diabetes de larga data y con presencia de otras comorbilidades. Su reconocimiento temprano puede facilitar el manejo de estos pacientes y a su vez disminuir los costos asociados a pruebas e intervenciones innecesarias con el objetivo de evitar complicaciones asociadas con la enfermedad.
Palabras clave:
diabetes mellitus
sistema cardiovascular
sistema nervioso autónomo
síncope
Cardiac autonomic diabetic neuropathy is a condition in which impairment of the autonomic control of the cardiovascular system leads to a myriad of symptoms, ranging from mild exercise intolerance to sudden cardiac death. Even though its exact prevalence is unknown, it is believed that it is highly prevalent in patients with long-standing diabetes, particularly those who have other pathologic conditions. Early detection is expected to have a positive impact in patient treatment, lowering costs associated with unnecessary tests and treatments, while at the same time avoiding disease-related complications.
Keywords:
diabetes mellitus
cardiovascular system
autonomic nervous system
syncope
Full text is only aviable in PDF
Bibliografía
[1.]
V. Spallone, D. Ziegler, R. Freeman, et al.
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management.
Diabetes Metab Res Rev, (2011),
[2.]
R. Pop-Busui, P.A. Low, B.H. Waberski, et al.
Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
Circulation, 119 (2009), pp. 2886-2893
[3.]
P.A. Low, L.M. Benrud-Larson, D.M. Sletten, et al.
Autonomic symptoms and diabetic neuropathy: a population-based study.
Diabetes Care, 27 (2004), pp. 2942-2947
[4.]
D. Ziegler, F.A. Gries, H. Muhlen, W. Rathmann, M. Spuler, F. Lessmann.
Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group.
Diabete & Metabolisme, 19 (1993), pp. 143-151
[5.]
P. Valensi, J. Paries, J.R. Attali.
Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications--the French multicenter study.
Metabolism, 52 (2003), pp. 815-820
[6.]
F. Ayad, M. Belhadj, J. Paries, J.R. Attali, P. Valensi.
Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications.
Diabet Med, 27 (2010), pp. 804-811
[7.]
T. Laitinen, J. Lindstrom, J. Eriksson, et al.
Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance.
Diabet Med, 28 (2011), pp. 699-704
[8.]
R.E. Maser, B.D. Mitchell, A.I. Vinik, R. Freeman.
The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis.
Diabetes Care, 26 (2003), pp. 1895-1901
[9.]
I.A. O’Brien, J.P. McFadden, R.J. Corrall.
The influence of autonomic neuropathy on mortality in insulin-dependent diabetes.
The Quarterly Journal of Medicine, 79 (1991), pp. 495-502
[10.]
D.J. Ewing, I.W. Campbell, B.F. Clarke.
Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications.
Annals of Internal Medicine, 92 (1980), pp. 308-311
[11.]
R. Pop-Busui.
Cardiac autonomic neuropathy in diabetes: a clinical perspective.
Diabetes Care, 33 (2010), pp. 434-441
[12.]
Y. Kadoi.
Anesthetic considerations in diabetic patients. Part I: preoperative considerations of patients with diabetes mellitus.
Journal of Anesthesia, 24 (2010), pp. 739-747
[13.]
I. Oakley, L. Emond.
Diabetic cardiac autonomic neuropathy and anesthetic management: review of the literature. AANA Journal.
, 79 (2011), pp. 473-479
[14.]
A.I. Vinik, R.E. Maser, B.D. Mitchell, R. Freeman.
Diabetic autonomic neuropathy.
Diabetes Care, 26 (2003), pp. 1553-1579
[15.]
P. Kempler, S. Tesfaye, N. Chaturvedi, et al.
Blood pressure response to standing in the diagnosis of autonomic neuropathy: the EURODIAB IDDM Complications Study.
Arch Physiol Biochem, 109 (2001), pp. 215-222
[16.]
C. Voulgari, I. Moyssakis, D. Perrea, D. Kyriaki, N. Katsilambros, N. Tentolouris.
The association between the spatial QRS-T angle with cardiac autonomic neuropathy in subjects with Type 2 diabetes mellitus.
Diabet Med, 27 (2010), pp. 1420-1429
[17.]
R. Pop-Busui, G.W. Evans, H.C. Gerstein, et al.
Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Diabetes Care, 33 (2010), pp. 1578-1584
[18.]
C.T. Prince, A.M. Secrest, R.H. Mackey, V.C. Arena, L.A. Kingsley, T.J. Orchard.
Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes.
Diabetes Care, 33 (2010), pp. 652-657
[19.]
A.J. Scholte, J.D. Schuijf, V. Delgado, et al.
Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability.
European Journal of Nuclear Medicine and Molecular Imaging, 37 (2010), pp. 1698-1705
[20.]
D.J. Ewing, C.N. Martyn, R.J. Young, B.F. Clarke.
The value of cardiovascular autonomic function tests: 10 years experience in diabetes.
Diabetes Care, 8 (1985), pp. 491-498
[21.]
The.
effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT).
Diabetologia, 41 (1998), pp. 416-423
[22.]
S. Omboni, A.A. Smit, J.J. van Lieshout, J.J. Settels, G.J. Langewouters, W. Wieling.
Mechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failure.
Clinical Science, 101 (2001), pp. 609-618
[23.]
J.J. van Lieshout, A.D. ten Harkel, W. Wieling.
Physical manoeuvres for combating orthostatic dizziness in autonomic failure.
Lancet, 339 (1992), pp. 897-898
[24.]
C. Podoleanu, R. Maggi, M. Brignole, et al.
Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled study.
Journal of the American College of Cardiology, 48 (2006), pp. 1425-1432
[25.]
A.A. Smit, W. Wieling, J. Fujimura, et al.
Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction.
Clinical autonomic research: official Journal of the Clinical Autonomic Research Society, 14 (2004), pp. 167-175
[26.]
A. Moya, R. Sutton, F. Ammirati, et al.
Guidelines for the diagnosis and management of syncope (version 2009).
European Heart Journal, 30 (2009), pp. 2631-2671
[27.]
V.E. Claydon, R. Hainsworth.
Salt supplementation improves orthostatic cerebral and peripheral vascular control in patients with syncope.
Hypertension, 43 (2004), pp. 809-813
[28.]
J. Finke, I. Sagemuller.
[Fludrocortisone in the treatment of orthostatic hypotension: ophthalmodynamography during standing(author's transl)].
Deutsche Medizinische Wochenschrift (1946), 100 (1975), pp. 1790-1792
[29.]
A.D. Ten Harkel, J.J. Van Lieshout, W. Wieling.
Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone.
Journal of Internal Medicine, 232 (1992), pp. 139-145
[30.]
J.J. van Lieshout, A.D. ten Harkel, W. Wieling.
Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure.
Clinical autonomic research: official Journal of the Clinical Autonomic Research Society, 10 (2000), pp. 35-42
[31.]
D. Ziegler.
Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
Treatments in Endocrinology, 3 (2004), pp. 173-189
[32.]
D. Ziegler, H. Schatz, F. Conrad, F.A. Gries, H. Ulrich, G. Reichel.
Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie.
Diabetes Care, 20 (1997), pp. 369-373
Copyright © 2013. Sociedad Colombiana de Cardiología y Cirugía Cardiovascular